Cargando…
Rate of breast biopsy referrals in female BRCA mutation carriers aged 50 years or more: a retrospective comparative study and matched analysis
PURPOSE: To evaluate the total biopsy and positive biopsy rates in women at high risk of breast cancer compared to the general population. METHODS: The study group consisted of 330 women with pathogenic variants (PVs) in BRCA1/2 attending the dedicated multidisciplinary breast cancer clinic of a ter...
Autores principales: | Pomerantz, Adi, Tsoref, Daliah, Grubstein, Ahuva, Wadhawker, Sonya, Rapson, Yael, Gadiel, Itay, Goldvaser, Hadar, Feldhamer, Ilan, Hammerman, Ariel, Shochat, Tzipora, Sharon, Eran, Kedar, Inbal, Yerushalmi, Rinat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090689/ https://www.ncbi.nlm.nih.gov/pubmed/35391652 http://dx.doi.org/10.1007/s10549-021-06498-9 |
Ejemplares similares
-
3,3-Diindolylmethane (DIM): a nutritional intervention and its impact on breast density in healthy BRCA carriers. A prospective clinical trial
por: Yerushalmi, Rinat, et al.
Publicado: (2020) -
Second-Line Treatment of Her2-Positive Metastatic Breast Cancer: Trastuzumab beyond Progression or Lapatinib? A Population Based Cohort Study
por: Hammerman, Ariel, et al.
Publicado: (2015) -
Efficacy and Safety of the Addition of Internal Mammary Irradiation to Standard Adjuvant Radiation in Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis
por: Korzets, Yasmin, et al.
Publicado: (2022) -
The impact of endogenous estrogen exposures on the characteristics and outcomes of estrogen receptor positive, early breast cancer
por: Korzets, Yasmin, et al.
Publicado: (2021) -
COVID-19 in a patient receiving adjuvant breast cancer chemotherapy with granulocyte olony-stimulating factor (G-CSF) support: A case report
por: Yerushalmi, Rinat, et al.
Publicado: (2021)